Additionally, although our study indicates that CFTR mutations do not affect the final ICSI clinical outcomes, considering that no pathogenic variants were found in some CBAVD patients, there are other unknown genetic factors that require further research. This evidence concerns the gene CFTR and congenital bilateral aplasia of vas deferens from CFTR mutation.